Table 4.
Comparison of the baseline characteristics between patients with and without event
Patients without event N=252 (88%) |
Patients with event N=33 (12%) |
P value | |
Clinical characteristics | |||
Age at repair—years | 2.6 (2.2–35.6) | 6.2 (2.2–29.9) | 0.023 |
Age at baseline—years | 29.3 (22.2–65.8) | 47.5 (33.1–67.5) | <0.001 |
Primary repair | 172 (68) | 14 (42) | 0.003 |
NYHA functional class I | 210 (83) | 19 (58) | 0.001 |
NT-proBNP—pg/mL | 120 (59–983) | 434 (191–1871) | <0.001 |
No device (ICD, PM, CRT) | 236 (94) | 27 (82) | 0.011 |
QRS duration—ms | 142±25 | 156±27 | 0.004 |
Echocardiography data | |||
LVEDD—mm | 46±6 | 50±8 | 0.016 |
LVESD—mm | 31±6 | 35±9 | 0.012 |
LVEF—% | 59±8 | 57±11 | 0.31 |
LAVI—mL/m2 | 24±11 | 38±21 | 0.004 |
RA area—cm2 | 18±6 | 25±6 | <0.001 |
RV-RA gradient—mm Hg | 30±12 | 39±10 | <0.001 |
RV FAC—% | 39±8 | 35±11 | 0.03 |
Severe tricuspid regurgitation | 1 (0.4%) | 2 (6.3%) | 0.002 |
Severe pulmonary regurgitation | 47 (18%) | 12 (36%) | 0.014 |
RV GLS—% | −16±5 | −15±6 | 0.38 |
RV Dyssynchrony Index—ms | 49±31 | 41±18 | 0.21 |
IVSD—ms | 103±50 | 130±65 | 0.09 |
IVED—ms | −3.3±19 | 2.5±19 | 0.12 |
CMR data | |||
LV EDVI—mL | 86±19 | 99±31 | 0.99 |
RV EDVI—mL | 124±31 | 139±56 | 0.95 |
RV EF—% | 43±13 | 48±8 | 0.11 |
LV EF—% | 57±7 | 53±11 | 0.02 |
Exercise data | |||
Peak VO2—mL/kg/min | 22±9 | 18±11 | 0.03 |
Peak heart rate—bpm | 161±24 | 133±33 | 0.003 |
VE/VCO2 | 26±5 | 30±5 | <0.001 |
Data are expressed as N (% of total), mean±SD or median (IQR) unless otherwise specified.
CMR, cardiac MR; CRT, cardiac resynchronization therapy; EDVI, end-diastolic volume indexed; RV FAC, right ventricular fractional area change; GLS, global longitudinal strain; ICD, Implantable cardioverter-defibrillator; IVED, interventricular ejection delay; IVSD, interventricular shortening delay; LAVI, left atrial volume indexed; LVEDD, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic diameter; NT-proBNP, N-terminal pro–B-type natriuretic peptide; NYHA, New York Heart Association; PM, pacemaker; RV EDV, right ventricular end-diastolic volume; RVEF, right ventricular ejection fraction; VE/VCO2, minute ventilation/carbon dioxide output; VO2, oxygen uptake.